L ung cancer, the second most common cancer in the United States, remains the leading cause of cancer-related deaths among US women and men.
1, 2 The state of Kentucky leads the nation in lung cancer incidence and mortality rates 3 ; however, within the state, rates differ with respect to the region of residence. From 2000 to 2013, the age-adjusted lung cancer incidence and mortality rates in the Appalachian region of Kentucky were higher than the rates in the non-Appalachian region (Table 1) . 4, 5 Moreover, significant differences in all age-adjusted cancer mortality and incidence rates for the period 2000-2013 could be observed between Kentuckians residing in Appalachian and non-Appalachian regions (Table 1) . 6, 7 A number of factors may influence the risk of developing subsequent primary cancers, including genetic predisposition; environmental exposures; infections; immunosuppression; effects of treatment of the initial cancer; the role of drug-metabolizing enzymes; DNA repair proteins; drug pharmacokinetics 8, 9 ; and the lifestyle of individuals, including effects from tobacco and alcohol consumption.
The present study examined various factors associated with the development of subsequent primary cancers in Kentucky patients first diagnosed as having lung cancer. The factors were age, sex, race, histology, grade and stage of tumor, and performance of radiation or surgery on the primary tumor. The main goal, however, was to determine whether patients with lung cancer from Appalachian Kentucky were more likely to develop subsequent primary cancers than patients residing in non-Appalachian Kentucky. Besides higher incidence and mortality rates of cancers in the Appalachian region, Appalachian Kentucky is characterized by a high prevalence of smoking, especially among boys and men, as well as occupational and environmental exposure to coal mining, low socioeconomic status, lack of commercial health insurance coverage, a shortage of health professionals, and poor general health (eg, high rates of obesity, diabetes mellitus, heart disease, stroke). 16, 17 Considering the high mortality rates for patients with lung cancer, the clinical significance of this study lies in the potential to explore factors that affect the risk of subsequent primary cancers as one of the causes of death for survivors of lung cancer. This knowledge can contribute to the improvement of healthrelated quality of life for this population.
Early screening and detection have contributed significantly to a decrease in cancer-related mortality. There has, however, been a notable increase in multiple primary malignancies among patients with cancer, a phenomenon that has captured the attention of clinicians and epidemiologists. 9, 10, 13 As such, determining the risk factors for multiple primary cancers is important for cancer research.
Methods

Study Population and Design
This was a retrospective, population-based cohort study of patients in Kentucky (N = 26,456) aged 20 years and older, diagnosed as having primary lung cancer (with only non-small-cell carcinomas) between January 1, 2000 and December 31, 2013. Patients with lung cancer in Kentucky were defined as the target population, because lung cancer incidence and mortality rates are notably higher in Kentucky than they are nationally. 3 The study population was drawn from the Kentucky Cancer Registry, which is both an National Cancer Institute Surveillance, Epidemiology, and End Results cancer registry and a Centers for Disease Control and Prevention National Program of Cancer Registries participant. This study was approved by the institutional review board of the University of Kentucky and received the Exemption Certification for Protocol.
Cases were excluded if the patient was diagnosed as having second primary cancers within 3 months after the diagnosis of their first primary lung cancer. Cases also were excluded if the patient changed his or her residence (ie, moving from the Appalachian to the non-Appalachian region or vice versa).
Subjects were followed to determine whether they developed subsequent primary cancers and to examine whether there were differences in the development of multiple primary cancers in patients with lung cancer residing in the Appalachian versus non-Appalachian regions of Kentucky. The primary hypothesis of the study was that patients with lung cancer residing in Appalachian Kentucky were more likely to develop multiple primary cancers compared with patients with lung cancer residing in non-Appalachian Kentucky. The study also examined other factors associated with the development of another primary cancer in patients with lung cancer.
Data Analysis
Statistical analyses were carried out using SAS version 9.4 (SAS Institute, Cary, NC). Descriptive analyses such as means, standard deviations, quartiles, and ranges were examined for continuous variables, and frequencies and percentages were examined for categorical variables. Results were examined by main exposure (Appalachian versus non-Appalachian Kentucky), which was of primary interest in this study.
Bivariate analysis, such as the Pearson χ 2 and the Fisher exact tests, were conducted to identify the association between Appalachian status and categorical covariates. The WilcoxonMann-Whitney test was used to determine associations between Appalachian status and continuous covariates. Two-sided P values <0.05 were considered statistically significant.
This study assessed the unadjusted and adjusted associations for independent covariates and the event of interest: development [4] [5] [6] [7] of multiple primary cancers, regardless of the site. As such, the Cox proportional hazards model was carried out with development of multiple primary cancers as the censor variable and the time variable, which expressed both observed survival from the time of the lung cancer diagnosis for those who did not develop another primary cancer and the difference in observed survival between the first and second diagnoses for those who developed another primary cancer. The final multivariable hazards model was derived using backward elimination, starting with the main effects of all of the potential predictors, which were significant in bivariate analysis. Because of the nature of the retrospective data, the chosen design of a retrospective, population-based cohort study was the best option. A case-control study design would not be appropriate here; it would have required a defined cutoff time during which a patient could have developed a subsequent primary cancer, because it would have been critical for investigators to identify cases and controls correctly. This, in turn, would automatically reduce the sample size and decrease the power. In addition, the Cox proportional hazards model allowed for the control of potential confounding variables and the consideration of censoring cases of death resulting from various causes which would not have been possible with a logistic regression.
Results
Univariate Descriptive Statistics and Bivariate Findings
According to the results presented in Table 2 , patients with lung cancer residing in the Appalachian versus non-Appalachian regions of Kentucky were significantly different with regard to age at diagnosis, sex, race, histology, tumor stage, and tumor grade. Significant differences also were found with respect to lung cancer treatment, including radiotherapy and surgery, as well as the proportion of patients who developed subsequent primary cancers. Slightly higher percentages of those who developed multiple primaries (4.21% vs 3.62%) were observed among patients from the non-Appalachian region. No significant differences were observed between these two geographic regions regarding the site of the second primary cancer (P = 0.0532), however.
Bivariate Findings: Unadjusted Analysis Using Cox Proportional Hazards Regression Models
The results of the univariate Cox proportional hazards models (Table 3) indicated that there were no statistically significant differences between Appalachian and non-Appalachian lung cancer populations in Kentucky with respect to the hazards of developing a subsequent primary cancer (hazard ratio [HR] 1.002, P = 0.9713). The model also did not demonstrate significant results for the race covariate, which compared the black population with the white population and to representatives of other races (HR 1.121, P = 0.3946 and HR 0.327, P = 0.2667, respectively).
In contrast, univariate Cox proportional hazards regressions revealed other statistically significant associations. For instance, age (HR 1.014, P <0.0001), male sex (HR 1.165, P = 0.0138), non-small-cell carcinoma histologic type (HR 0.682, P = 0.0002), receiving radiotherapy (HR 0.811, P = 0.0035), having undergone surgery (HR 1.700, P <0.0001), and having distant (HR 0.514, P <0.0001) or ungraded tumors (HR 0.595, P <0.0001).
Multivariable Findings: Adjusted Analysis Using the Cox Proportional Hazards Regression Model
The final adjusted multivariable hazards model (Table 4) indicated that there were no statistically significant differences between Appalachian and non-Appalachian lung cancer populations of Kentucky with respect to the hazards of developing a subsequent primary cancer (HR 1.002, P = 0.9713). The adjusted multivariable model, however, revealed that increasing age at diagnosis of the first primary lung cancer by 1 year, male sex, and surgery increased the hazards of developing another primary cancer (respectively, HR 1.015, P = 0.0001; 1.169, P = 0.012; and 1.446, P = 0.0003). Conversely, having a stage IV tumor decreased the hazards of the outcome by 31.6% compared with the patients with stage II tumors (HR 0.684, P = 0.0015).
Although not statistically significant, an association was observed with radiotherapy. As compared with those who did not receive radiation as their treatment for lung cancer, patients who underwent radiation therapy had a 9.6% greater hazard of developing multiple primary cancers (95% confidence interval [CI] 0.932-1.290), and those with unknown status had a 7.6% lesser hazard (95% CI 0.764-1.117).
Patients with grade III and grade IV tumors had a 7.8% lesser hazard as compared with those with grade I and grade II tumors; however, the association was not statistically significant (95% CI 0.805-1.056). Having stage III tumors also had an observed protective effect from developing multiple primary cancers, but the results were not significant (HR 0.942, 95% CI 0.821-1.082). Those patients whose status was unknown had a 1.7% greater hazard of developing multiple primary cancers, but again, the association was not statistically significant (95% CI 0.723-1.433).
Discussion
Based on the descriptive statistics and bivariate results presented in Table 2 , the Appalachian and non-Appalachian patients with lung cancer were different with respect to several factors. These factors included age at diagnosis of lung cancer, survival time, sex, race, histology, stage and grade of tumors, and treatment (radiation and surgery). There was a significant difference in the number of primary cancers developed during a lifetime in Appalachian and non-Appalachian residents; however, the present study was a negative study. No evidence was found to reject the null hypothesis, which suggested that patients with lung cancer in Kentucky residing in the Appalachian region have a greater hazard of developing multiple primary cancers. Neither univariate nor multivariable hazards models revealed any differences between the Appalachian and non-Appalachian patients with lung cancer with respect to the development of subsequent primary cancers. It was concluded that even though the variable number of primary cancers was treated as a categorical variable, the statistical significance of the Pearson χ 2 presented in Table 2 could be explained by a large sample size, and therefore, the power of the test.
Overall, the multivariable proportional hazards model revealed the results that were in line with previous research or that could be intuitively derived based on descriptive and bivariate findings. For instance, it was expected that patients diagnosed as having the first primary lung cancer at an older age would have a greater hazard of developing another primary cancer, because typically incidence rates of many cancers increase with age. 13 Consistent with previous research, the occurrence of a subsequent primary cancer was not influenced by a specific histologic type of tumors (eg, squamous, adenocarcinoma). 18 Other studies have demonstrated that a more aggressive, invasive treatment increased overall survival for patients with multiple lung cancers, [19] [20] [21] which could be associated with the development of subsequent primary cancers. 13 This is consistent with our finding that surgery was likely to be associated with developing a second primary cancer, because patients who had surgery were likely to live longer and thus had a greater opportunity to develop a subsequent cancer. In contrast, patients who were diagnosed as having stage IV lung cancer had short survival times and therefore a lesser hazard to develop a second primary cancer. Moreover, patients with unknown tumor grade status also had a lesser hazard of developing an additional primary cancer. This could be because the differentiation and definition of grade in patients with stage IV tumors can be nearly impossible. A previous study found that radiotherapy increased survival in patients with locally advanced non-small-cell lung cancer who could not tolerate surgical or drug treatments, particularly when radiotherapy was combined with chemotherapy. 22 Moreover, previous research revealed an increased risk of subsequent cancers in patients with thyroid cancer who received radioactive iodine treatment. 23 Also, the increased risk of cancers such as osteosarcomas, melanomas, and soft-tissue sarcomas was found to be related to radiotherapy that had been received previously. 9 Our results show that radiation treatment did indeed increase the hazard of subsequent cancers; however, this association was not statistically significant.
Previous work has shown that female patients with lung cancer, especially those with stage II tumors, have better survival compared with men 13 because surgical procedures were performed on women with stage II tumors more frequently than in men. 13, 24 Women also are more likely than men to develop adenocarcinomas, 13, 25 and as Fu et al showed, patients with any histologic type of stage II tumors other than adenocarcinomas had lower survival rates. 24 In addition, early stages of lung cancer are detected more frequently in women as a result of their undergoing annual mammograms. The results of this study demonstrated, unexpectedly, that men had almost a 17% greater hazard of developing subsequent cancers compared with female subjects. 24 A possible explanation is the presence of a confounding variable-smoking. Unfortunately, it was not possible to control for smoking in this analysis and it is known that smoking is a major risk factor for many cancers, lung cancer in particular, and for the development of a second primary cancer. 9, 13 In addition, there is a higher prevalence of smoking in the male population of Kentucky 26,27 as compared to women. As such, further research is required to examine the influence of smoking as a potential confounding factor and the impact of comorbidities and occupational exposures, because they could not be assessed in this study as a result of a lack of data.
Another limitation of the present study was the large volume of missing data for important covariates. Separate subgroups indicating categories with unknown or missing values were included in the analysis. This was done to prevent the exclusion of a large number of subjects, which would have reduced the power of the statistical tests.
Conclusions
This was a retrospective, population-based cohort study of Kentucky patients diagnosed as having primary lung cancer between 2000 and 2013. The study population was drawn from the Kentucky Cancer Registry. Subjects were studied to determine whether there were differences between the Appalachian and the non-Appalachian populations of Kentucky with regard to the development of subsequent primary cancers. To our knowledge, no previous study has been conducted with this purpose. This is a negative study. Although unadjusted associations revealed some differences between the Appalachian and nonAppalachian populations of patients with lung cancer in Kentucky, the adjusted multivariable Cox proportional hazards regression analysis indicated that there were no differences between Appalachian and non-Appalachian patients with lung cancer regarding the development of subsequent primary cancers. This study revealed, however, that increased age at diagnosis of the first primary lung cancer, male sex, and surgical treatment were associated with a greater hazard of developing a subsequent primary cancer, whereas having stage IV or ungraded tumors decreased the hazard of developing subsequent primary cancers.
